AGI Dermatics
1985
FOUNDED
M&A
STATUS
M&A
LATEST DEAL TYPE
Description
Provider of skin diseases and DNA repair treatment solutions. The company was engaged in skin photobiology, dedicating research and development to DNA repair, solar impact on the immune system and its proprietary brand, Remergent(R).
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Acquirer
Estee Lauder
Primary Office
- 205 Buffalo Avenue
- Freeport, NY 11520
- United States
+1 (516) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore AGI Dermatics’s full profile, request a free trial.
AGI Dermatics Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Merger/Acquisition | 30-Sep-2008 | 000 | Completed | Product Development | ||
| 1. Early Stage VC (Series A) | 08-Apr-2008 | 000 | 000 | 0000 | Completed | Product Development |
AGI Dermatics Former Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Spring Mountain Capital | Growth/Expansion | Minority | 000 0000 | 000000 0 | ||
| Trevi Health Capital | Growth/Expansion | Minority | 000 0000 | 000000 0 | ||
| WHI Group | Other | Minority | 000 0000 | 000000 0 |